Paper1949136
Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole.
Daramola OO and 5 others. Trans R Soc Trop Med Hyg, 1991. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole. Papers, record 1949136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1949136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria | Major topic |
| Plasmodium falciparum | Major topic |
| Trimethoprim, Sulfamethoxazole Drug Combination | Major topic |
| Animals | |
| Child | |
| Child, Preschool | |
| Diagnosis, Differential | |
| Drug Resistance | |
| Gambia | |
| Humans | |
| Infant | |
| Respiratory Tract Infections |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32731386 | Repurposing Drugs to Fight Hepatic Malaria Parasites. | Molecules | 2020 | https://conductscience.org/library/papers/32731386 | PubMed |
| 25915616 | Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy. | PLoS One | 2015 | https://conductscience.org/library/papers/25915616 | PubMed |
| 25247995 | Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. | PLoS Med | 2014 | https://conductscience.org/library/papers/25247995 | PubMed |
| 23451110 | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. | PLoS One | 2013 | https://conductscience.org/library/papers/23451110 | PubMed |
| 19528269 | In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19528269 | PubMed |
| 17516701 | Cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in nigerian children : a controlled clinical trial. | Clin Drug Investig | 2004 | https://conductscience.org/library/papers/17516701 | PubMed |
| 11969121 | Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria. | Sci Prog | 2002 | https://conductscience.org/library/papers/11969121 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DHFR | 1719 | PubTator's text mining | https://conductscience.org/library/genes/1719 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1949136
GET https://conductscience.org/api/papers/v1/1949136/authors